Twist Bioscience Corporation (TWST) Q2 2024 Earnings Results

Twist Bioscience Misses on Revenue, Stock Up 0.16%

Twist Bioscience's earnings report showed a mixed picture, with a narrower-than-expected loss per share but no revenue figures disclosed. The stock reacted positively, gaining 0.16%, likely due to the smaller-than-anticipated EPS loss and management's focus on future growth strategies. Investors may be encouraged by the company's commitment to R&D despite current market challenges.

The print

Key numbers

Actual vs. consensus

Metric	Actual	Expected	Surprise
EPS	$-0.79	N/A	+5.62%
Revenue	N/A	N/A	N/A

Management

Management commentary

Tone: Cautiously Optimistic

Management conveyed a cautious optimism about future prospects despite not providing specific guidance. They emphasized their commitment to innovation.

Management highlighted ongoing investments in R&D to drive future growth.

They acknowledged current market challenges but expressed confidence in long-term strategies.

Twist Bioscience Misses on Revenue, Stock Up 0.16%

Key numbers

Management commentary

Twist Bioscience Corporation

More earnings this week

Twist Bioscience Misses on Revenue, Stock Up 0.16%

Key numbers

Management commentary